Vor Biopharma (VOR) Enterprise Value (2020 - 2026)
Vor Biopharma's (VOR) quarterly Enterprise Value came in at -$491.5 million in Q1 2026, down 718.73% year-on-year from $79.4 million in Q1 2025, and down 7.98% on a QoQ basis from -$455.2 million in Q4 2025.
Vor Biopharma (VOR) Enterprise Value (2020 - 2026) Analysis & Trends
Vor Biopharma (VOR) has 7 years of Enterprise Value data on file, last reported at -$491.5 million in Q1 2026.
- On a quarterly basis, Enterprise Value fell 718.73% year-over-year to -$491.5 million in Q1 2026; TTM through Mar 2026 was -$491.5 million, a 718.73% decrease from a year earlier, with the FY2025 full-year figure at -$455.2 million, down 395.19% from the prior year.
- Enterprise Value for Q1 2026 stood at -$491.5 million, down from -$455.2 million in the prior quarter.
- Over the last five years, Enterprise Value for VOR reached as high as -$60.0 million in Q1 2025 and fell as low as -$491.5 million in Q1 2026.
- Historically, Enterprise Value has averaged -$183.5 million across 5 years, with a median of -$160.1 million in 2023.
- Across the five-year window, Enterprise Value jumped 60.77% in 2024 and sank 718.73% in 2026, its largest moves.
- Year by year, Enterprise Value stood at -$230.2 million in 2022, then jumped by 40.42% to -$137.2 million in 2023, then jumped by 32.99% to -$91.9 million in 2024, then sank by 395.19% to -$455.2 million in 2025, then fell by 7.98% to -$491.5 million in 2026.
- Per Business Quant data, the three most recent Enterprise Value figures were -$491.5 million in Q1 2026, -$455.2 million in Q4 2025, and -$170.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -61.40 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -4.79 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -32.26 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | -5.18 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -1.91 Bn |
| 10 | Vor Biopharma | 187.37 Mn | 187.37 Mn | - | -491.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -491.53 Mn |
| Dec 31, 2025 | -455.21 Mn |
| Sep 30, 2025 | -170.46 Mn |
| Jun 30, 2025 | -200.57 Mn |
| Mar 31, 2025 | -60.04 Mn |
| Dec 31, 2024 | -91.93 Mn |
| Sep 30, 2024 | -62.81 Mn |
| Jun 30, 2024 | -85.94 Mn |
| Mar 31, 2024 | -107.48 Mn |
| Dec 31, 2023 | -137.18 Mn |
| Sep 30, 2023 | -160.10 Mn |
| Jun 30, 2023 | -186.90 Mn |
| Mar 31, 2023 | -210.20 Mn |
| Dec 31, 2022 | -230.25 Mn |
| Sep 30, 2022 | -136.07 Mn |
| Jun 30, 2022 | -151.09 Mn |
| Mar 31, 2022 | -181.62 Mn |
| Dec 31, 2021 | -207.47 Mn |
| Sep 30, 2021 | -225.97 Mn |
| Jun 30, 2021 | -244.63 Mn |